Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say
Portfolio Pulse from Vandana Singh
The demand for weight loss drugs like Novo Nordisk's Ozempic and Eli Lilly's Mounjaro has led to a rise in counterfeit and diverted drugs, posing health risks. Authorities are actively intercepting these illegal drugs, while pharmaceutical companies work to combat the issue.
October 11, 2024 | 3:36 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Eli Lilly's Mounjaro is also affected by counterfeiting due to high demand. The company is addressing the issue with law enforcement and cybersecurity firms.
Eli Lilly is dealing with counterfeit Mounjaro, which could impact its market position. The company's efforts to work with authorities may help control the situation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Novo Nordisk's Ozempic is being counterfeited and diverted due to high demand, posing health risks. The company is working with authorities to combat this issue.
The news highlights the issue of counterfeit Ozempic, which could affect Novo Nordisk's reputation and sales. However, the company's proactive measures with authorities may mitigate long-term impacts.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80